As of October 29, 2015, 18 out of 24 subjects have completed 12-month follow-up interviews in our largest Phase 2 study of MDMA-assisted psychotherapy for U.S. veterans, firefighters, and police officers with chronic, treatment-resistant PTSD. Led by Principal Investigator Michael Mithoefer, M.D., and Co-Therapist Annie Mithoefer, B.S.N., the data from this study are now being prepared for analysis and publication in a peer-reviewed scientific journal. “After 10 years practicing emergency medicine followed by 25 years practicing psychiatry with a focus on PTSD, I am well versed in a range of existing treatments,” writes Dr. Mithoefer in his upcoming article for the Winter 2015 MAPS Bulletin. “However, millions of people with PTSD do not respond to existing treatments, and presently 26 veterans are committing suicide every day in the U.S. alone. I have not encountered any other treatment approach to helping these people that is nearly as promising and compelling as MDMA-assisted psychotherapy, using a medicine only a few times in an optimal set and setting to catalyze profoundly healing, often life-changing, experiences.”